Furthermore, the conolidine molecule didn't interact with the classical receptors, that means that it wouldn't compete from opioid peptides to bind to these receptors.Conolidine CONOCB2™, that has been code-named 'natures morphine,' is considered to be one of several most significant suffering reduction discoveries designed in the last ten years.